The Canadian Drug Policy Coalition provides an overview of drug-related challenges in Canada and pathways toward sustainable solutions anchored in public health and harm reduction.
AFEW's survey sheds light on the impact of the COVID-19 pandemic and associated restrictions on civil society in terms of their staff's health, operations and sustainability.
Pew Charitable Trusts offer an analysis on approaches state policymakers can take to make naloxone widely available to people at risk of experiencing or witnessing an overdose.
Steve Rolles et al. argue the regulation of illicit substances provides an effective avenue to manage the risks of drugs and drug markets, both for those who use them and for wider society.
INPUD reveals how the HIV epidemic in Kyrgyzstan is dangerously outpacing the country's response in terms of government aid and community-led initiatives to combat the crisis.
Aidsfonds warns the dearth of funding for key populations in the HIV response (only 2% of the total) jeopardises international agreements to end AIDS by 2030.
Shirley-Beavan et al. analyse the role of stigma and structural violence, gender-based violence, criminalisation and the absence of women-specific services.
Clean Start provides formerly-incarcerated women with avenues for healing, education and employment, breaking cycles of criminalisation and vulnerability.
Bonn et al. urge for a continuation of effective responses implemented during the pandemic, including emergency safe-supply prescribing and housing provision, and further efforts to address the harms of criminalisation and prohibition.
The Colombian Observatory of Organized Crime draws on lessons from the production of opium and cannabis for medical purposes to suggest pathways toward viable legal markets for coca products.
